InsidersTradesSigma
Explore the complete record of transactions filed by CLAUSEN PETER, Chief Operating Officer. Officer active across 1 company, notably Nuo Therapeutics, Inc.. Aggregated, 1 reports have been published. History available since 29 April 2022. The latest transaction was filed on 29 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Peter Clausen is the Chief Scientific Officer and Chief Operating Officer at Nuo Therapeutics, Inc. He is responsible for the strategic direction of operations and research and development. His expertise is essential for ensuring innovation and efficiency within the company.